Published in

BioMed Central, Critical Care, S3(16), 2012

DOI: 10.1186/cc11765

Springer, Intensive Care Medicine, 4(39), p. 754-763, 2013

DOI: 10.1007/s00134-012-2798-3

Links

Tools

Export citation

Search in Google Scholar

Pancreatic stone protein as a novel marker for neonatal sepsis

Journal article published in 2012 by Luregn J. Schlapbach, Rolf Graf ORCID, Andreas Woerner, Matteo Fontana, Urs Zimmermann-Baer, David Glauser, Eric Giannoni, Thierry Roger ORCID, Mathias Nelle, Christoph Müller, Martin Stocker, C. Mueller
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Green circle
Postprint: archiving allowed
Upload
Green circle
Published version: archiving allowed
Upload
Policy details
Data provided by SHERPA/RoMEO

Abstract

Early-onset sepsis (EOS) is one of the main causes for the admission of newborns to the neonatal intensive care unit. However, traditional infection markers are poor diagnostic markers of EOS. Pancreatic stone protein (PSP) is a promising sepsis marker in adults. The aim of this study was to investigate whether determining PSP improves the diagnosis of EOS in comparison with other infection markers.